24Serious

David Eckstein

David Eckstein

Ask VT AI

View News Summary

Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
Russia tests nuclear-powered cruise missile, experts raise concerns over technical challenges and proliferation risks.
British cyclists dominate UCI Track Worlds with Madison gold and one-two pursuit finish.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novartis nears $70 billion acquisition of Avidity Biosciences to expand its RNA therapeutics pipeline for neuromuscular diseases.
Russia tests nuclear-powered cruise missile, experts raise concerns over technical challenges and proliferation risks.
British cyclists dominate UCI Track Worlds with Madison gold and one-two pursuit finish.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from David Eckstein